• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Intensive blood pressure control in patients with a history of heart failure: the Systolic Blood Pressure Intervention Trial (SPRINT).

作者信息

Pareek Manan, Vaduganathan Muthiah, Byrne Christina, Mikkelsen Astrid Duus, Kristensen Anna Meta Dyrvig, Biering-Sørensen Tor, Kragholm Kristian Hay, Omar Massar, Olsen Michael Hecht, Bhatt Deepak L

机构信息

Heart & Vascular Center, Brigham and Women's Hospital, Harvard Medical School, 75 Francis St., Boston, MA 02115, USA.

Department of Internal Medicine, Yale New Haven Hospital, Yale School of Medicine, New Haven, CT, USA.

出版信息

Eur Heart J Cardiovasc Pharmacother. 2022 May 5;8(3):E12-E14. doi: 10.1093/ehjcvp/pvab085.

DOI:10.1093/ehjcvp/pvab085
PMID:34902012
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9071486/
Abstract
摘要

相似文献

1
Intensive blood pressure control in patients with a history of heart failure: the Systolic Blood Pressure Intervention Trial (SPRINT).心力衰竭病史患者的强化血压控制：收缩压干预试验（SPRINT）
Eur Heart J Cardiovasc Pharmacother. 2022 May 5;8(3):E12-E14. doi: 10.1093/ehjcvp/pvab085.
2
Potential Deaths Averted and Serious Adverse Events Incurred From Adoption of the SPRINT (Systolic Blood Pressure Intervention Trial) Intensive Blood Pressure Regimen in the United States: Projections From NHANES (National Health and Nutrition Examination Survey).在美国采用收缩压干预试验（SPRINT）强化血压治疗方案避免的潜在死亡和发生的严重不良事件：来自美国国家健康与营养检查调查（NHANES）的预测
Circulation. 2017 Apr 25;135(17):1617-1628. doi: 10.1161/CIRCULATIONAHA.116.025322. Epub 2017 Feb 13.
3
Heart failure and the discrepancy between trials of intensive blood pressure management: an analysis of individual patient data.心力衰竭与强化血压管理试验之间的差异：一项个体患者数据分析。
Clin Res Cardiol. 2018 Jul;107(7):565-569. doi: 10.1007/s00392-018-1218-2. Epub 2018 Feb 26.
4
Effect of Intensive Blood Pressure Treatment on Heart Failure Events in the Systolic Blood Pressure Reduction Intervention Trial.收缩压降低干预试验中强化血压治疗对心力衰竭事件的影响。
Circ Heart Fail. 2017 Apr;10(4). doi: 10.1161/CIRCHEARTFAILURE.116.003613.
5
Assessment of Risk of Harm Associated With Intensive Blood Pressure Management Among Patients With Hypertension Who Smoke: A Secondary Analysis of the Systolic Blood Pressure Intervention Trial.高血压患者强化血压管理相关伤害风险评估：收缩压干预试验的二次分析。
JAMA Netw Open. 2019 Mar 1;2(3):e190005. doi: 10.1001/jamanetworkopen.2019.0005.
6
Intensive vs. standard blood pressure control and vascular procedures: insights from the Systolic Blood Pressure Intervention Trial (SPRINT).
Eur Heart J Cardiovasc Pharmacother. 2021 May 23;7(3):e35-e37. doi: 10.1093/ehjcvp/pvaa093.
7
Applicability and cost-effectiveness of the Systolic Blood Pressure Intervention Trial (SPRINT) in the Chinese population: A cost-effectiveness modeling study.在中国人群中开展收缩压干预试验（SPRINT）的适用性和成本效益：一项成本效益建模研究。
PLoS Med. 2021 Mar 4;18(3):e1003515. doi: 10.1371/journal.pmed.1003515. eCollection 2021 Mar.
8
Effectiveness of blood pressure-lowering treatment by the levels of baseline Framingham risk score: A post hoc analysis of the Systolic Blood Pressure Intervention Trial (SPRINT).基于基线 Framingham 风险评分水平的降压治疗效果：SPRINT（收缩压干预试验）的事后分析。
J Clin Hypertens (Greenwich). 2019 Dec;21(12):1813-1820. doi: 10.1111/jch.13720. Epub 2019 Oct 31.
9
Effect of intensive blood pressure lowering on cardiovascular outcomes based on cardiovascular risk: A secondary analysis of the SPRINT trial.强化降压对基于心血管风险的心血管结局的影响：SPRINT 试验的二次分析。
Eur J Prev Cardiol. 2019 Feb;26(3):238-245. doi: 10.1177/2047487318800741. Epub 2018 Sep 26.
10
Impact of the SPRINT Trial on Hypertension Management.SPRINT 试验对高血压管理的影响。
Annu Rev Med. 2018 Jan 29;69:81-95. doi: 10.1146/annurev-med-050416-024516.

引用本文的文献

1
Combination of sacubitril/valsartan and blockade of the PI3K pathway enhanced kidney protection in a mouse model of cardiorenal syndrome.沙库巴曲缬沙坦与PI3K通路阻断联合使用可增强心肾综合征小鼠模型的肾脏保护作用。
Eur Heart J Open. 2023 Sep 29;3(6):oead098. doi: 10.1093/ehjopen/oead098. eCollection 2023 Nov.
2
The association of intensive blood pressure treatment and non-fatal cardiovascular or serious adverse events in older adults with mortality: mediation analysis in SPRINT.强化血压治疗与老年人死亡率相关的非致死性心血管或严重不良事件的关联：SPRINT 中的中介分析。
Eur J Prev Cardiol. 2023 Aug 1;30(10):996-1004. doi: 10.1093/eurjpc/zwad132.
3
Updates for Cardio-Kidney Protective Effects by Angiotensin Receptor-Neprilysin Inhibitor: Requirement for Additional Evidence of Kidney Protection.血管紧张素受体-脑啡肽酶抑制剂对心肾保护作用的更新：需要更多肾脏保护证据。
J Am Heart Assoc. 2023 Apr 18;12(8):e029565. doi: 10.1161/JAHA.122.029565. Epub 2023 Apr 17.
4
Blood Pressure and Glycemic Control Among Ambulatory US Adults With Heart Failure: National Health and Nutrition Examination Survey 2001 to 2018.美国心力衰竭门诊成年人的血压和血糖控制情况：2001 年至 2018 年全国健康和营养调查。
Circ Heart Fail. 2022 May;15(5):e009229. doi: 10.1161/CIRCHEARTFAILURE.121.009229. Epub 2022 Apr 28.

本文引用的文献

1
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America.2017年美国心脏病学会/美国心脏协会/美国心力衰竭学会对2013年美国心脏病学会基金会/美国心脏协会心力衰竭管理指南的重点更新：美国心脏病学会/美国心脏协会临床实践指南特别工作组及美国心力衰竭学会的报告
Circulation. 2017 Aug 8;136(6):e137-e161. doi: 10.1161/CIR.0000000000000509. Epub 2017 Apr 28.
2
A Randomized Trial of Intensive versus Standard Blood-Pressure Control.强化与标准血压控制的随机试验
N Engl J Med. 2015 Nov 26;373(22):2103-16. doi: 10.1056/NEJMoa1511939. Epub 2015 Nov 9.
3
Quantifying the paradoxical effect of higher systolic blood pressure on mortality in chronic heart failure.量化慢性心力衰竭中较高收缩压对死亡率的矛盾影响。
Heart. 2009 Jan;95(1):56-62. doi: 10.1136/hrt.2007.134973. Epub 2008 Jul 24.